SUSAN RHYAN: Open Payments
NPI 1164419792 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 35 payments from 10 companies in 2025. Trend: 2023 $146 · 2024 $477 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $175 |
| ABBVIE INC. | 13 | $169 |
| Janssen Biotech, Inc. | 4 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Organon LLC | 5 | $41 |
| GENZYME CORPORATION | 1 | $36 |
| Galderma Laboratories, L.P. | 1 | $21 |
| UCB, Inc. | 1 | $14 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, ILUMYA, Sotyktu, VTAMA, COSENTYX, Rhapsido.
Industry payments across IA — which companies pay providers there.
